Compass Therapeutics, Inc. (CMPX)
NASDAQ: CMPX · Real-Time Price · USD
5.45
+0.05 (0.93%)
At close: Apr 9, 2026, 4:00 PM EDT
5.50
+0.05 (0.92%)
Pre-market: Apr 10, 2026, 5:32 AM EDT
Compass Therapeutics Market Cap
Compass Therapeutics has a market cap or net worth of $981.48 million as of April 10, 2026. Its market cap has increased by 227.84% in one year.
Market Cap
981.48M
Enterprise Value
782.40M
1-Year Change
227.84%
Ranking
Category
Stock Price
$5.45
Market Cap Chart
Since April 5, 2021, Compass Therapeutics's market cap has increased from $435.34M to $981.48M, an increase of 125.45%. That is a compound annual growth rate of 17.60%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 9, 2026 | 981.48M | 2.76% |
| Dec 31, 2025 | 955.12M | 378.75% |
| Dec 31, 2024 | 199.50M | 0.34% |
| Dec 29, 2023 | 198.83M | -68.61% |
| Dec 30, 2022 | 633.47M | 105.02% |
| Dec 31, 2021 | 308.98M | -29.02% |
| Apr 5, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Inventiva | 1.02B |
| uniQure | 999.22M |
| KalVista Pharmaceuticals | 985.52M |
| Annexon | 982.10M |
| Inhibrx Biosciences | 976.19M |
| Evommune | 964.93M |
| UroGen Pharma | 930.81M |
| GH Research | 929.20M |